Home > Initiatives > Policy & Legal Initiatives
The success of cell therapies requires a supportive legal and regulatory environment. GPI provides legal support to cases that affect stem cell research. GPI continues to advance the field by shaping favorable public policy, creating regulatory harmonization and providing advice and guidance to stakeholders.
- GPI submitted amicus curiae ("friend of the court") briefs in the United States District Court for the District of Columbia and the Court of Appeals, supporting federal funding for embryonic stem cell research in Sherley v. Sebelius, a case challenging President Obama's Executive Order and National Institutes of Health (NIH) guidelines. (Read pdf: GPI brief, GPI and CAMR brief)
- GPI led a two-year (2004-2005) public awareness and lobbying campaign, which galvanized a global movement, successfully lobbying the United Nations to reject a treaty that called for a prohibition of nuclear transfer (therapeutic cloning), saving the research by a single vote in the UN's Legal Committee. The campaign sent 35,000 fax letters to UN missions; organized a science conference and a patients' press conference at the UN; produced a taped appeal to the General Assembly by Christopher Reeve; led a global media campaign; and lobbied UN diplomats.
- GPI filed comments to the National Institutes of Health (NIH) regarding the Draft Guidelines for Human Stem Cell Research. (pdf letters: 2009, 2010)
- GPI disseminates press releases, provides media interviews and appearances, publishes Op-Ed pieces and supplies commentaries on issues and news impacting the field.
- GPI maintains affiliation with 19 coalitions, alliances and collaborations covering the gamut of stakeholder groups, including board membership in the Coalition for Advancement of Medical Research (CAMR), Americans for Cures Foundation, and Alliance for Regenerative Medicine (ARM). In addition, GPI has relationships with dozens of academic centers around the world.
- San Antonio biotech leaders in Atlanta to win back global stem cell summit
December 11, 2015
- SA bioscience companies strike new deal to expand scope of stem cell research
December 10, 2015
- Two UC Davis experts among speakers at World Stem Cell Summit
December 09, 2015
The World Stem Cell Summit and RegMed Capital Conference Overview
The World Stem Cell Summit is the largest interdisciplinary meeting of stem cell science and regenerative medicine stakeholders. The 2016 World Stem Cell Summit #WSCS16 will convene at the Palm Beach Convention Center, West Palm Beach, Florida, December 06-09, 2016. Visit www.worldstemcellsummit.com for more information.
Genetics Policy Institute (GPI) and the Regenerative Medicine Foundation (RMF) Announce Merger Plan
The Genetics Policy Institute (GPI), producer of the annual World Stem Cell Summit, and the Regenerative Medicine Foundation (RMF) have agreed to merge in order to leverage their resources in the advancement of stem cell research, regenerative medicine and other advanced technologies targeting cures.
Bernard Siegel's TedX talk "Stem Cells and the Transformative Power of Hope"
Bernard Siegel, a leader of the global stem cell advocacy movement and founder of the World Stem Cell Summit, describes how grassroots activists have contributed to the advancement of stem cell research, one of the greatest scientific breakthroughs of our time.
- Regenerative Medicine Workshop
Hilton Head Island, South Carolina
- BEINGS 2015
- Organ Bioengineering and Banking Workshop
- White House Office of Science and Technology Policy:
OSTP Roundtable on Technological Solutions Scarcity & Impairment
- ISCT 2015: Coming of Age